首页> 美国卫生研究院文献>Schizophrenia Research and Treatment >Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders
【2h】

Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders

机译:药物利用是开发抗神经精神疾病药物的新机会

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Better the drugs you know than the drugs you do not know. Drug repurposing is a promising, fast, and cost effective method that can overcome traditional de novo drug discovery and development challenges of targeting neuropsychiatric and other disorders. Drug discovery and development targeting neuropsychiatric disorders are complicated because of the limitations in understanding pathophysiological phenomena. In addition, traditional de novo drug discovery and development are risky, expensive, and time-consuming processes. One alternative approach, drug repurposing, has emerged taking advantage of off-target effects of the existing drugs. In order to identify new opportunities for the existing drugs, it is essential for us to understand the mechanisms of action of drugs, both biologically and pharmacologically. By doing this, drug repurposing would be a more effective method to develop drugs against neuropsychiatric and other disorders. Here, we review the difficulties in drug discovery and development in neuropsychiatric disorders and the extent and perspectives of drug repurposing.
机译:比您不知道的药物要好。重新利用药物是一种有前途的,快速且具有成本效益的方法,可以克服针对神经精神病和其他疾病的传统从头药物发现和开发挑战。由于了解病理生理现象的局限性,针对神经精神疾病的药物发现和开发非常复杂。另外,传统的从头开发和发现药物是危险,昂贵和耗时的过程。利用现有药物的脱靶效应,出现了一种替代方法,即重新利用药物。为了确定现有药物的新机会,对我们而言,从生物学和药理学角度理解药物的作用机制至关重要。通过这样做,重新设定药物用途将是开发针对神经精神病和其他疾病的药物的更有效方法。在这里,我们回顾了神经精神疾病中药物发现和开发的困难以及药物用途的范围和观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号